{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380865820399398409.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Sabine Brechignac"}],"foaf:familyName":[{"@value":"Brechignac"}],"foaf:givenName":[{"@value":"Sabine"}]}],"career":[{"institution":{"notation":[{"@value":"Hematology, Avicenne Hospital, APHP, University Paris XIII, Bobigny, France"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360865820399398400","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1182/blood-2021-148152"},{"@type":"URI","@value":"https://ashpublications.org/blood/article/138/Supplement%201/83/477533/Ixazomib-and-Daratumumab-without-Dexamethasone-I"}],"notation":[{"@value":"Ixazomib and Daratumumab without Dexamethasone (I-Dara) in Elderly Frail RRMM Patients. a Multicenter Phase 2 Study (IFM 2018-02) of the Intergroupe Francophone Du Myélome (IFM)"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1182/blood-2021-148152_MCMWSenetvb4ixBcZqDAKEkVU4j"}]}